Explore the innovative world of TCR-Mimic antibodies at Nona Biosciences, where cutting-edge technology targets intracellular tumor antigens for enhanced therapeutic outcomes. Our platform leverages high-affinity, specificity-engineered antibodies to revolutionize cancer treatment and beyond.
- High Specificity and Affinity: TCR-Mimic antibodies exhibit exceptional binding strength to target antigens, outperforming traditional TCRs.
- Enhanced Efficacy: Achieves potent, concentration-dependent cytotoxicity in preclinical studies against tumor cells.
- Versatile Applications: Suitable for a range of applications, including cancer immunotherapy and precision medicine.
- Innovative Design: Incorporates Fc-silencing modifications and anti-CD3 nanobodies for optimized therapeutic potential
Please fill in the form below to request a download of this brochure.
TCRm Ab Download Request Form
Nona Biosciences Brochure: TCRm Antibody